2026 NPPES data Medical Oncology Physician NPI 1346683547 M.D., PH.D.
Verify on CMS →

MARY BOLTON, M.D., PH.D.

Medical Oncology Physician in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
982
Medicare Part D claims · 60 beneficiaries · Medical Oncology Physician avg: 689
Industry payments
$19.89
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARY BOLTON, M.D., PH.D. is a Medical Oncology Physician ([object Object]) practicing in SEATTLE, Washington with a Medicare Part D prescribing footprint of 982 claims across 60 beneficiaries . Industry payments of $19.89 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARY BOLTON, M.D., PH.D. filed 982 Medicare Part D claims in 2023 across SEATTLE, Washington. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MARY BOLTON, M.D., PH.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MARY BOLTON, M.D., PH.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 04/08/2013

NPI 1346683547

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

982 43% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Washington

How Medical Oncology Physician compares to other specialties among Washington providers

Washington providers

Medical Oncology Physician share within Washington

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Washington

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARY BOLTON, M.D., PH.D. is a Medical Oncology Physician provider practicing in SEATTLE, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1346683547. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARY BOLTON, M.D., PH.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D., PH.D. credentials at 9730 3RD AVE NE STE 208, SEATTLE, WA, 98115, with a listed phone of (206) 522-5646. NPI 1346683547 was issued on 04/08/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOLTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 982 prescription claims written by this provider, covering 60 Medicare beneficiaries and totaling roughly $84K in drug spend, with an opioid prescribing rate of 3.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

9730 3RD AVE NE STE 208
SEATTLE, WA 98115

Provider Details

NPI 1346683547
Specialty Medical Oncology Physician
Credentials M.D., PH.D.
Gender Female
NPI Issued 04/08/2013

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARY BOLTON, M.D., PH.D.. Source: openpaymentsdata.cms.gov.

Total received

$20

Largest payer

Novo Nordisk Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to MARY BOLTON, M.D., PH.D.. To verify MARY BOLTON, M.D., PH.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

982
Total Claims
$84K
Total Drug Cost
60
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,322
Total Day Supply
68,655
Generic Drug Cost
$22K
Opioid Claims
34 (3.5% rate)

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
0.75
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Rosuvastatin Calcium
89
Amlodipine Besylate
74
Losartan Potassium
52
Metformin Hcl
50
Levothyroxine Sodium
47
Metoprolol Succinate
32
Spironolactone
31
Chlorthalidone
30
Tamsulosin Hcl
28
Atorvastatin Calcium
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MARY BOLTON, M.D., PH.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MARY BOLTON, M.D., PH.D.'s 982 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as BOLTON.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARY BOLTON, M.D., PH.D.'s specialty?
MARY BOLTON, M.D., PH.D. specializes in Medical Oncology Physician and practices in SEATTLE, Washington. Credentials: M.D., PH.D..
How much does MARY BOLTON, M.D., PH.D. prescribe under Medicare Part D?
In 2023, MARY BOLTON, M.D., PH.D. wrote 982 Medicare Part D claims totaling $84K in drug costs for 60 beneficiaries.
Where is MARY BOLTON, M.D., PH.D. located?
MARY BOLTON, M.D., PH.D. is located at 9730 3RD AVE NE STE 208, SEATTLE, WA, 98115. Phone: (206) 522-5646.
What is MARY BOLTON, M.D., PH.D.'s NPI number?
MARY BOLTON, M.D., PH.D.'s National Provider Identifier (NPI) is 1346683547, issued on 04/08/2013.
Does MARY BOLTON, M.D., PH.D. prescribe opioids?
Yes, MARY BOLTON, M.D., PH.D. had 34 opioid claims in 2023 with an opioid prescribing rate of 3.5%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MARY BOLTON, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, MARY BOLTON, M.D., PH.D.'s most frequently prescribed drugs include Rosuvastatin Calcium, Amlodipine Besylate, Losartan Potassium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARY BOLTON, M.D., PH.D. accept Medicare?
MARY BOLTON, M.D., PH.D. appears in CMS Medicare data with 982 Part D claims and 60 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARY BOLTON, M.D., PH.D.'s credentials?
MARY BOLTON, M.D., PH.D.'s NPI is 1346683547 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology